Repligen To Acquire Tantti Laboratory, Adding Novel Macroporous Chromatography Technology; Terms Not Disclosed
Portfolio Pulse from Benzinga Newsdesk
Repligen Corporation (RGEN) announced its acquisition of Tantti Laboratory, which will add novel macroporous chromatography technology to its portfolio. This acquisition is expected to enhance Repligen's expansion into new modality markets with scalable purification solutions, synergizing with its existing AVIPure and OPUS columns.
July 29, 2024 | 8:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Repligen Corporation (RGEN) is acquiring Tantti Laboratory to enhance its product offerings with novel macroporous chromatography technology. This acquisition is expected to support Repligen's expansion into new modality markets and synergize with its existing AVIPure and OPUS columns.
The acquisition of Tantti Laboratory by Repligen is likely to positively impact RGEN's stock price in the short term. The addition of novel macroporous chromatography technology will enhance Repligen's product offerings and support its expansion into new modality markets, which is expected to be well-received by investors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100